Delaying carbohydrate absorption

"Delaying carbohydrate absorption" refers to a therapeutic or dietary approach rather than a single molecule or receptor. The principle is to slow down the enzymatic breakdown and uptake of dietary carbohydrates in the small intestine, thereby flattening postprandial rises in blood glucose and insulin. This is achieved pharmacologically (alpha-glucosidase inhibitors such as acarbose) or nutritionally (soluble fibers). This approach is relevant in the management of diabetes and metabolic syndrome and works primarily by targeting the activity of digestive enzymes (not by directly binding a single protein target). Most carbohydrate absorption occurs via transport of monosaccharides (glucose, galactose, fructose) using sodium-dependent cotransporters and facilitated diffusion in the small intestine. "Delaying carbohydrate absorption" is not a single molecular target but a process modulated by inhibiting specific digestive enzymes or altering gut transit, often used in metabolic disease management. If you need information on a *specific molecular target* involved in carbohydrate absorption (e.g., sodium-glucose cotransporter 1 (SGLT1), alpha-glucosidase), specify the molecule or enzyme for structured data.

Other names

Slowed carbohydrate uptakeReduced carbohydrate absorptionDelayed glucose absorption

Inhibition of intestinal enzymes (alpha-amylase and alpha-glucosidase), which delays breakdown of starches/disaccharides to monosaccharides, slowing their absorption. Increase in intestinal transit time or viscosity, typically via soluble dietary fiber, to slow glucose entry into circulation.